Biomanufacturing at Scale
Where Biology Meets Scale
The world’s premier gathering where biology becomes the factory of the future.
The Biomanufacturing track at SynBioBeta 2026 brings together startups, industry leaders, and investors pioneering the technologies of tomorrow’s industrial manufacturing. From continuous fermentation to real-time bioprocess monitoring, this track explores how synthetic biology is enabling efficient and supply-chain resilient production at a global scale.
Why Biomanufacturing Matters
Biology is the new industrial engine — biology is replacing fossil-based processes with cleaner, more flexible manufacturing.
Production is becoming programmable — modular platforms and automated scale-up are accelerating time-to-market.
Profitability and sustainability align — biomanufacturing can reduce costs at scale and cut emissions, meeting growing consumer demands.
Who you'll meet
Industrial Biotech Pioneers – Leaders scaling bio-based production and turning innovative processes into commercially viable manufacturing.
Scientists & Process Innovators – Experts advancing fermentation technologies, automation, and AI-driven processes to turn biology into industrial-scale solutions.
Capital & Strategic Partners – Investors supporting startups and corporates to unite cutting-edge biomanufacturing technologies with market impact.
What to expect
Technical Sessions – Discover how automation, real-time monitoring, and modular bioprocess platforms are transforming industrial production.
Insights into Market-Proven Strategies – Learn from leaders who have successfully brought bio-based production platforms and products to commercial scale.
Collaboration Opportunities – Engage with innovators, investors, and corporates driving growth and sustainability in bio-based manufacturing.
Biomanufacturing isn’t just about replacing petrochemicals or traditional processes — it’s about reimagining our entire industrial landscape. At SynBioBeta 2026, discover how startups, corporates, and investors are scaling bio-based production, driving cost parity, and opening opportunities for sustainable growth. Join us to define the next era of bio-driven industry.
Confirmed Speakers
Sessions
1
Continuous fermentation promises higher yields, lower costs, and more sustainable biomanufacturing—but realizing its potential requires overcoming technical and operational hurdles. From controlling contamination to optimizing productivity and scaling systems, innovators are tackling the bottlenecks that have slowed adoption. This session dives into cutting-edge strategies, platform designs, and case studies showing how continuous fermentation is moving from concept to commercial reality. Learn from leaders who are driving efficiency, reliability, and scalability in fermentation processes, and explore how overcoming these challenges can unlock faster, more sustainable production of bio-based ingredients, chemicals, and therapeutics across industries.
[…]
2
Scaling bio-based products requires integrated technical collaboration across strain engineering, fermentation, downstream processing, and analytics. Full-stack approaches—where startups, CDMOs, and platform technology providers align early on—can optimize yield, reduce variability, and lower cost of goods (COGS) at commercial scale. This session explores case studies of cross-company collaboration, from co-development of microbial strains and bioreactor designs to shared process analytics and predictive modeling. Hear how teams are breaking down technical silos to accelerate scale-up, improve reproducibility, and create competitive, sustainable manufacturing solutions that bring synthetic biology products from the lab to the market efficiently.
[…]
3
Choosing the right biomanufacturing strategy starts with matching the product to the optimal organism, media, feedstock, and manufacturing platform. These decisions impact yield, scalability, cost, and process efficiency. This session explores frameworks for evaluating how different organisms and engineering platforms align with product goals, as well as how feedstock selection shapes economics and sustainability. Experts will share case studies highlighting successful technical collaboration across strain design, process development, and supply chain planning. Attendees will gain practical insights into selecting the right biological systems and production strategies to bring bio-based products to market efficiently and competitively.
[…]
4
Scaling bio-based products to commercial production requires balancing technical readiness with market and financial realities. This session examines the capital investments, regulatory planning, and supply chain strategies necessary to move beyond the pilot stage. Experts will share lessons on aligning production capacity with demand forecasts, managing operational risk, and structuring partnerships that unlock funding and market access. Attendees will gain practical insights into navigating investor expectations, scaling efficiently without compromising quality, and making strategic decisions that ensure products can succeed commercially while meeting evolving market needs and sustainability goals.
[…]
